{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:12:03Z","timestamp":1790626323566,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/jnci\/dju289","type":"journal-article","created":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:07:19Z","timestamp":1411690039000},"source":"Crossref","is-referenced-by-count":121,"title":["Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality"],"prefix":"10.1093","volume":"106","author":[{"given":"Diego","family":"Munoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Near","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolien T.","family":"van Ravesteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde B.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguzhan","family":"Alagoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Burnside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ali Ergun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline A. M.","family":"Heijnsdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha K.","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Trentham-Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne S.","family":"Mandelblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia K.","family":"Plevritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"key\n\t\t\t\t20170521020129_CIT0001","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-4419-0685-4_17","article-title":"Chapter 17: Principles of Breast Cancer Therapy","volume-title":"Breast Cancer Epidemiology","author":"Kurian","year":"2010"},{"issue":"6","key":"key\n\t\t\t\t20170521020129_CIT0002","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3322\/CA.57.6.326","article-title":"A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015","volume":"57","author":"Sedjo","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"key\n\t\t\t\t20170521020129_CIT0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"key\n\t\t\t\t20170521020129_CIT0004","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.2009.1498","article-title":"Rethinking screening for breast cancer and prostate cancer","volume":"302","author":"Esserman","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t20170521020129_CIT0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"key\n\t\t\t\t20170521020129_CIT0006","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrc1739","article-title":"Biomarkers in cancer staging, prognosis and treatment selection","volume":"5","author":"Ludwig","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"key\n\t\t\t\t20170521020129_CIT0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/bcr2238","article-title":"Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer","volume":"11","author":"Oakman","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20170521020129_CIT0008","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"key\n\t\t\t\t20170521020129_CIT0009","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","article-title":"Gene-expression signatures in breast cancer","volume":"360","author":"Sotiriou","year":"2009","journal-title":"N Engl J Med"},{"issue":"9472","key":"key\n\t\t\t\t20170521020129_CIT0010","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"issue":"14","key":"key\n\t\t\t\t20170521020129_CIT0011","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.295.14.1658","article-title":"Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer","volume":"295","author":"Berry","year":"2006","journal-title":"JAMA"},{"issue":"17","key":"key\n\t\t\t\t20170521020129_CIT0012","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med"},{"issue":"21","key":"key\n\t\t\t\t20170521020129_CIT0013","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"key\n\t\t\t\t20170521020129_CIT0014","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamainternmed.2013.307","article-title":"Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy","volume":"173","author":"Kerlikowske","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"17","key":"key\n\t\t\t\t20170521020129_CIT0015","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1200\/JCO.2010.32.3550","article-title":"Breast cancer adjuvant therapy: time to consider its time-dependent effects","volume":"29","author":"Jatoi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"key\n\t\t\t\t20170521020129_CIT0016","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-151-10-200911170-00010","article-title":"Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms","volume":"151","author":"Mandelblatt","year":"2009","journal-title":"Ann Intern Med"},{"issue":"9310","key":"key\n\t\t\t\t20170521020129_CIT0017","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","article-title":"Long-term effects of mammography screening: updated overview of the Swedish randomised trials","volume":"359","author":"Nystrom","year":"2002","journal-title":"Lancet"},{"issue":"7317","key":"key\n\t\t\t\t20170521020129_CIT0018","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bmj.323.7317.829","article-title":"Quality of Cochrane reviews: assessment of sample from 1998","volume":"323","author":"Olsen","year":"2001","journal-title":"BMJ"},{"issue":"8","key":"key\n\t\t\t\t20170521020129_CIT0019","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-155-8-201110180-00005","article-title":"Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study","volume":"155","author":"Kerlikowske","year":"2011","journal-title":"Ann Intern Med"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jncimonographs\/lgj006","article-title":"Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach","author":"Berry","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0021","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jncimonographs\/lgj013","article-title":"A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends","author":"Clarke","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0022","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jncimonographs\/lgj007","article-title":"The Wisconsin Breast Cancer Epidemiology Simulation Model","author":"Fryback","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0023","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jncimonographs\/lgj008","article-title":"The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods","author":"Mandelblatt","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jncimonographs\/lgj012","article-title":"A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000","author":"Plevritis","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/jncimonographs\/lgj009","article-title":"The MISCAN-Fadia continuous tumor growth model for breast cancer","author":"Tan","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0026","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jncimonographs\/lgj016","article-title":"Changing patterns in breast cancer incidence trends","author":"Holford","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key\n\t\t\t\t20170521020129_CIT0027","article-title":"Human Mortality Database. Berkeley: University of California, Berkeley"},{"issue":"6","key":"key\n\t\t\t\t20170521020129_CIT0028","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10552-005-0693-8","article-title":"Modeling the dissemination of mammography in the United States","volume":"16","author":"Cronin","year":"2005","journal-title":"Cancer Causes Control"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jncimonographs\/lgj003","article-title":"Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975\u20131999","author":"Mariotto","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"36","key":"key\n\t\t\t\t20170521020129_CIT0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jncimonographs\/lgj005","article-title":"Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality","author":"Cronin","year":"2006","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"21","key":"key\n\t\t\t\t20170521020129_CIT0031","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/jnci\/94.21.1626","article-title":"Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975\u20131999","volume":"94","author":"Mariotto","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"9132","key":"key\n\t\t\t\t20170521020129_CIT0032","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(98)03301-7","article-title":"Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists\u2019 Collaborative Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"key\n\t\t\t\t20170521020129_CIT0033","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0360-3016(94)90515-0","article-title":"The influence of young age on outcome in early stage breast cancer","volume":"30","author":"Fowble","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"key\n\t\t\t\t20170521020129_CIT0034","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1445-2197.2005.03515.x","article-title":"Is age at diagnosis an independent prognostic factor for survival following breast cancer?","volume":"75","author":"Jayasinghe","year":"2005","journal-title":"ANZ J Surg"},{"issue":"4","key":"key\n\t\t\t\t20170521020129_CIT0035","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr2349","article-title":"Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells","volume":"11","author":"Fehm","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"9","key":"key\n\t\t\t\t20170521020129_CIT0036","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1373\/clinchem.2011.165068","article-title":"Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges","volume":"57","author":"Lianidou","year":"2011","journal-title":"Clin Chem"},{"issue":"5","key":"key\n\t\t\t\t20170521020129_CIT0037","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1200\/JCO.2011.38.6060","article-title":"Online Tool to Guide Decisions for BRCA1\/2 Mutation Carriers","volume":"30","author":"Kurian","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170521020129_CIT0038","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170521020129_CIT0039","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11136-008-9353-2","article-title":"Quality of life valuations of mammography screening","volume":"17","author":"Bonomi","year":"2008","journal-title":"Qual Life Res"},{"issue":"5","key":"key\n\t\t\t\t20170521020129_CIT0040","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.sla.0000245833.48399.9a","article-title":"Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care","volume":"245","author":"El-Tamer","year":"2007","journal-title":"Ann Surg"},{"issue":"9","key":"key\n\t\t\t\t20170521020129_CIT0041","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/0003-4819-156-9-201205010-00002","article-title":"Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk","volume":"156","author":"van Ravesteyn","year":"2012","journal-title":"Ann Intern Med"},{"issue":"9897","key":"key\n\t\t\t\t20170521020129_CIT0042","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)61094-6","article-title":"Two years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial","volume":"382","author":"Goldhirsch","year":"2013","journal-title":"Lancet"},{"issue":"16","key":"key\n\t\t\t\t20170521020129_CIT0043","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"issue":"16","key":"key\n\t\t\t\t20170521020129_CIT0044","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"issue":"14","key":"key\n\t\t\t\t20170521020129_CIT0045","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170521020129_CIT0046","article-title":"Amer Soc Clinical Oncology"},{"issue":"4","key":"key\n\t\t\t\t20170521020129_CIT0047","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/djq561","article-title":"The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment","volume":"103","author":"Chlebowski","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"key\n\t\t\t\t20170521020129_CIT0048","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/jnci\/djt243","article-title":"Sex Hormone Levels and Risk of Breast Cancer With Estrogen Plus Progestin","volume":"105","author":"Farhat","year":"2013","journal-title":"J Natl Cancer Inst"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/106\/11\/dju289\/17313250\/dju289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T17:36:39Z","timestamp":1503509799000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,9,25]]},"published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dju289","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,25]]}}}